Neuraxpharm appoints Vikas Mohan Sharma as Chief Medical Officer

Announcement

Neuraxpharm appoints Vikas Mohan Sharma as Chief Medical Officer

Share:
Share on twitter
Share on linkedin
Share on facebook

Neuraxpharm welcomes Vikas Mohan Sharma, to the Executive Committee as Chief Medical Officer

Vikas brings over 25 years of healthcare and clinical research experience leading high-value clinical & medical scientific teams across multiple therapeutic areas to deliver successful developmental and program milestones in large pharma and Clinical Research Organizations (CRO).

A psychiatrist by training, he has held positions as Chief Medical Officer at Quintiles, India (formerly IQVIA) and Global Head of Medicine for CNS, Retinal Health & Emerging Areas at Boehringer Ingelheim. He joins Neuraxpharm from Fortrea GmBH where he was Global Head for Neuroscience and Ophthalmology.

Vikas is well regarded as a key thought leader in CNS clinical research. He works as an independent ethics expert with the prestigious European Research Council and chairs multiple industry and global initiatives in the fields of digital biomarkers, CNS trial methodologies and precision mental health.

Our team looks forward to working with Vikas to further enhance the excellence and development of Neuraxpharm’s pipeline to deliver sustainable growth across all focus areas.